Prediction Platform, 2023 - Canada. As the company continues to develop new products to address oral cancer as well as other human cancers, Proteocyte AI hopes to continue making a positive impact on the lives of patients at risk of oral cancer, as well as increasing its reach to clinicians and patients globally, reducing the mortality, morbidity, and the financial burden of oral cancer. The STRATICYTE test is now commercially available to order in Canada and the US. ORDER THE TEST. PROTEOCYTE DOES THE REST. ORDER THE STRATICYTETM TEST ONLINE! Visit proteocyte.com or call: 1-833-5-PROTEO (1-833-577-6836) Or email: proteocyte@ patientcaresolutions.com. Proteocyte hopes to see STRATICYTE available globally in the near future. The sensitivity and specificity performance of the STRATICYTE test is comparable to other cancer prediction tools such as Mammaprint and Endopredict. “Early detection is the key to saving lives and improving outcomes related to oral cancer. Straticyte™ is an innovative new test that can help us to better stratify patients and personalize their treatment. ” -Dr. Deepak Kademani, DMD, MD, FACS, Fellowship Director, Head and Neck Oncologic and Reconstructive Surgery, Minnesota Oral and Facial Surgery Contact: Mark Hammar, Chief Executive Officer Email: info@proteocyte.com Company: Proteocyte AI Web Address: https://proteocyte.com/straticyte/ Dr. Barrie Renick Chief Medical Officer-Canada, Oral and Maxillofacial Surgeon, Toronto, Canada Dr. Anthony Morlandt Chief Medical Officer-USA, Head and Neck Surgeon / Oral Oncology, University of Alabama at Birmingham
RkJQdWJsaXNoZXIy MTUyMDQwMA==